Synthesis, Spectroscopic Inspection, Antibacterial, Molecular Docking, and DFT Analysis of Metal Chelates Incorporating Coumarin-Isatin Schiff Base with Proline as a Mixed Ligand
Abstract
In this work, the Schiff base ligand (COM-IST) was synthesized from the condensation of 6-aminocoumarin and isatin. The new Co(II), Ni(II), Cu(II), and Zn(II) complexes were synthesized from the Schiff base (COM-IST) with the proline (Pro) amino acid as a mixed ligand. The structure of the Schiff base was confirmed by FTIR, ¹H-, and ¹³C-NMR spectroscopy and CHN analysis. Its complexes were confirmed through FTIR, UV-vis spectroscopy, CHN analysis, magnetic susceptibility, XRD, and molar conductivity measurements. The spectral results indicate that the ligands exhibit bidentate behavior in all four complexes, and octahedral geometries are observed in each metal complex. The antibacterial activity of the prepared compounds was tested against various types of Gram-positive and negative bacteria. Molecular docking investigations proved that the ligand had intriguing interactions with the active sites of the receptors (DNA gyrase) for both bacterial strains. Frontier molecular orbitals (FMOs), various quantum chemical descriptors (QCDs), and molecular electrostatic potential (MEP) surfaces were computed using density functional theory (DFT) for the ligand and complex at the B3LYP functional with the 6-31G(++)d,p basis set for the ligand and the LANL2DZ basis set for the complexes.
Keywords
Thanks
References
- 1. Rodriguez-Enriquez F, Costas-Lago MC, Besada P, Alonso-Pena M, Torres-Terán I, Vina D, Fontenla JÁ, Sturlese M, Moro S, Quezada E, Teran C. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy. Bioorganic Chemistry. 2020 Nov 1;104:104203. Available from:
. - 2. García-Beltrán O, Mena NP, Aguirre P, Barriga-González G, Galdámez A, Nagles E, Adasme T, Hidalgo C, Núñez MT. Development of an iron-selective antioxidant probe with protective effects on neuronal function. PloS one. 2017 Dec 11;12(12): e0189043. Available from:
. - 3. Aguirre P, García-Beltrán O, Tapia V, Muñoz Y, Cassels BK, Núñez MT. Neuroprotective effect of a new 7, 8-dihydroxycoumarin-based Fe2+/Cu2+ chelator in cell and animal models of Parkinson’s disease. ACS Chemical Neuroscience. 2017 Jan 18;8(1):178-85. Available from:
. - 4. Shen YuFeng SY, Liu Lei LL, Feng ChenZhang FC, Hu Yang HY, Chen Cheng CC, Wang GaoXue WG, Zhu Bin ZB. Synthesis and antiviral activity of a new coumarin derivative against spring viraemia of carp virus.,Fish & Shellfish Immunology, 2018, 81, 57-66, Available from:
. - 5. Sahoo CR, Paidesetty SK, Sarathbabu S, Dehury B, Senthil Kumar N, Padhy RN. Molecular dynamics simulation, synthesis, and topoisomerase inhibitory actions of vanillin derivatives: a systematic computational structural integument. Journal of Biomolecular Structure and Dynamics. 2022 Dec 12;40(22):11653-63. Available from:
. - 6. Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L. Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human microRNA modulation. Molecules. 2019 Dec 23;25(1):63. Available from:
. - 7. Galvin CJ, Hobson M, Meng JX, Ierokomos A, Ivanov IE, Berger JM, Bryant Z. Single-molecule dynamics of DNA gyrase in evolutionarily distant bacteria, Mycobacterium tuberculosis and Escherichia coli. Journal of Biological Chemistry. 2023 May 1;299(5). Available from:
. - 8. Khan T, Sankhe K, Suvarna V, Sherje A, Patel K, Dravyakar B. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy. 2018 Jul 1;103:923-38. Available from:
.
Details
Primary Language
English
Subjects
Bioinorganic Chemistry
Journal Section
Research Article
Publication Date
May 3, 2026
Submission Date
November 8, 2025
Acceptance Date
March 26, 2026
Published in Issue
Year 2026 Number: 2026-1
